TABLE 4.

Antihypertensive drug consumption at baseline and follow-up. P values for the change from baseline within groups (paired data) are denoted in round brackets

		RDN	SHAM	P value group comparison
Baseline	Antihypertensive drugs (numbers)	4.1 ± 1.2	4.2 ± 1,1	0.96
	Antihypertensive drugs (DDD)	6.9 ± 2.7	6.8 ± 2.5	0.86
1 month	Antihypertensive drugs (numbers)	4.2 ± 1.2 (0.16)	4.2 ± 1.1 (1.00)	0.88
	Antihypertensive drugs (DDD)	7.0 ± 2.8 (0.61)	6.8 ± 2.5 (0.10)	0.80
	Patients with changes in drugs	14%	12%
3 months	Antihypertensive drugs (numbers)	4.2 ± 1.2 (0.66)	4.2 ± 1.2 (0.26)	0.79
	Antihypertensive drugs (DDD)	6.8 ± 2.7 (0.72)	7.0 ± 2.5 (0.14)	0.77
	Patients with changes in drugs	41%	24%
6 months	Antihypertensive drugs (numbers)	4.1 ± 1.2 (0.99)	4.2 ± 1.3 (0.45)	0.39
	Antihypertensive drugs (DDD)	6.5 ± 2.8 (0.19)	7.1 ± 2.5 (0.16)	0.72
	Patients with changes in drugs	46%	33%

No significant difference between groups and no significant changes within groups. DDD, daily defined dose; RDN, renal denervation.